一种向细胞因子受体的仿真体 (kineTAC) 工具箱,用于扩大细胞外向蛋白质降解的范围
Kaan Kumru1, Zi Yao1, Brandon B Holmes2,3
1Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.
bioRxiv : the preprint server for biology
|September 15, 2025
概括
这项研究扩展了细胞因子受体向嵌合体 (kineTACs) 工具箱,使得特定细胞中的向细胞外蛋白降解 (eTPD) 成为可能. 新的 kineTACs 为治疗应用提供了增强的功效和多功能性.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 药物发现 药物发现 药物发现
背景情况:
- 细胞外向蛋白降解 (eTPD) 为操纵细胞外蛋白质组提供了一种新的方法.
- 目前的eTPD方法通常依赖于广泛表达或肝脏受限受体,限制其特异性.
- 针对细胞因子受体的仿真体 (kineTACs) 使用与抗体结合的天然配体,通过CXCR7引导蛋白质降解.
研究的目的:
- 通过创建新的变体来显著扩展 kineTAC 工具箱.
- 探索这些新 kineTACs 对细胞类型选择性 eTPD 的潜力.
- 调查 kineTACs 在增强抗体药物合剂性能方面的实用性.
主要方法:
- 基于细胞因子,化学因子和生长因子构建了81种新的 kineTAC.
- 对 kineTACs 的表达分析,以评估它们是否适合进一步研究.
- 与现有结构相比,对 kineTAC 的结合亲和力和强度的评估.
- 评估 kineTAC 内化能力及其对抗体药物合物的影响.
主要成果:
- 在新建的81个 kineTAC 中,有55个在没有优化的情况下以合适的水平表达.
- 许多 kineTAC 向具有独特细胞类型表达特征的受体,从而实现特定的 eTPD.
- 几种新的 kineTAC 显示出比原来的基于CXCL12的 kineTAC 有更高的功效.
- 证明KineTAC的内部化能力可以提高抗体药物合剂的性能.
结论:
- 扩展的 kineTAC 工具箱为遗传编码,细胞类型选择性 eTPD.提供了多功能工具.
- 这些新型 kineTACs 提供了更好的功效和更广泛的适用于治疗策略.
- 这些发现表明, kineTACs对于优化eTPD和扩大其在向治疗中的使用可能是有价值的.
相关概念视频
Regulated Protein Degradation
8.7K
It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.7K
Conservative Site-specific Recombination and Phase Variation
6.7K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
6.7K
Transducer Mechanism: Enzyme-Linked Receptors
3.9K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.9K
Protein Complexes with Interchangeable Parts
2.9K
Groups of proteins may form a complex where each protein in this complex has a different role in the overall execution of the complex’s function. Often some of the proteins in the complex can be replaced by a closely related variant to give a complex that contains many of the same components yet is functionally distinct.
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
2.9K


